Skip to main content
. Author manuscript; available in PMC: 2020 Aug 1.
Published in final edited form as: J Pharm Sci. 2019 Mar 21;108(8):2748–2755. doi: 10.1016/j.xphs.2019.03.019

Figure 4.

Figure 4.

Cisplatin cytotoxicity with KELLY cells (n=3) (a) Dose dependent cisplatin cytotoxicity (LC50), (b) long term cytotoxicity of cisplatin loaded silk reservoirs (significantly effective until the time point labeled with a,b,c,d where a) 0.2 mg, b) 0.5 mg, c) 1 mg and d) 2 mg cisplatin, p<0.05).